DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials

Những quyển sách tương tự

• Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial.
  Bằng: Marnie L Elizaga, et al.
  Được phát hành: (2018-01-01)
• Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
  Bằng: Kenneth H Mayer, et al.
  Được phát hành: (2017-11-01)
• Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP^® DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults
  Bằng: Srilatha Edupuganti, et al.
  Được phát hành: (2020-12-01)
• HIV-exposed uninfected infants: elevated cord blood Interleukin 8 (IL-8) is significantly associated with maternal HIV infection and systemic IL-8 in a Kenyan cohort
  Bằng: Barbara Lohman-Payne, et al.
  Được phát hành: (2018-09-01)
• A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204).
  Bằng: Gavin J Churchyard, et al.
  Được phát hành: (2011-01-01)